Ai Powered Drug Delivery to Neuro and Cardiovascular Systems: Perspectives and Future Challenges. Questo articolo non è disponibile.Ai Powered Drug Delivery to Neuro and Cardiovascular Systems: Perspectives and Future Challenges

AI-Powered Drug Delivery to Neuro and Cardiovascular Systems: Perspectives and Future Challenges is a comprehensive reference covering the transformative potential of Artificial Intelligence (AI) in the realms of neuro and cardiovascular drug delivery. Designed to integrate and review the latest literature, this book provides an in-depth understanding of how AI is set to revolutionize clinical practices, protocols, and regulatory guidelines in therapeutic drug delivery. As AI and robotics continue to evolve, their role in enhancing precision, personalization, and efficiency in cardiovascular and neurological drug delivery becomes increasingly essential. The book opens with an introduction to the foundational concepts of AI in drug delivery, followed by a detailed examination of current AI practices in managing cardiovascular and neurological diseases. It progresses to explore AI-enhanced drug design and testing for cardiovascular conditions, and the application of AI in cardiac drug delivery vehicles. Insights into bioengineered heart and vessels, AI-inspired redox homeostasis, and targeted drug replenishment in cardiac matrix remodeling are thoroughly discussed. The text also covers novel avenues in mitochondrial drug retention, AI-assisted pharmaco and gene therapy for neurodegenerative diseases, and the role of AI in heart health. Further sections address the augmented optimization of medical side effects, neuromodulation with pharmacotherapy from an AI perspective, and smart systems for managing cerebrovascular accidents. The book concludes with a discussion on translational challenges and future directions in the field. This book is an invaluable resource for healthcare professionals, researchers, and students keen on understanding the dynamic interplay between AI and drug delivery systems. By offering insights into AI-driven prediction models, personalized drug regimens, and advanced robotic delivery mechanisms, it sets the stage for the next generation of cardiovascular and neurotherapeutic management. The perspectives, concepts, and innovations discussed are integral to shaping the future of cardiovascular and neurological healthcare.

Dr. Chandra P. Sharma is an Adjunct Professor, Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal University, and Hon. Emeritus Professor, College of Biomedical Engineering & Applied Sciences, Purbanchal University, Kathmandu, Nepal. Dr. Sharma is a Solid-State Physicist from IIT Delhi and received his training in Biomaterials area in the University of Utah with Prof. D.J. Lyman as a graduate student and in the University of Liverpool, England with Prof. D.F. Williams as a Post-Doctoral Research Associate. Dr. Sharma has been awarded FBSE (Fellow Biomaterials Science & Engineering) by The International Union of Societies for Biomaterials Science & Engineering (IUS-BSE) in 2008 and FBAO (Fellow Biomaterials and Artificial Organs) by Society for Biomaterials & Artificial Organs (India) (SBAOI) in 2011 and shares Whitaker and National Science Foundation Award – International Society for Artificial Organs (ISAO) USA, invited member ACS (2015-2018).

Dr. Finosh Thankam is an assistant professor and researcher in Tissue Engineering and Regenerative Medicine, in the Department of Translational Research, at the Western University of Health Sciences, in Pomona, CA. His undergraduate studies were in Biochemistry, before completing his post-graduate degree in Medical Biochemistry from Mahatma Gandhi University, in India. As a research fellow he was exposed to the new world of tissue engineering and regenerative medicine and published many original articles on various aspects of cardiac tissue engineering. His current research interests include investigating the pathogenesis of various musculoskeletal disorders, and cardiovascular diseases, and applying the knowledge and principles of tissue engineering to develop artificial tissue constructs to improve the care for the sufferers.

Rohan Goswami, M.D. is an advanced heart failure and transplant cardiologist in the Transplant Center at Mayo Clinic hospital in Jacksonville, Florida.

Dr. Goswami received his medical degree from the American University of the Caribbean School of Medicine, Sint Maarten, Netherlands Antilles, and went on to complete an internal medicine residency at The Stamford Hospital/Columbia University College of Physicians and Surgeons in Stamford, Connecticut, where he was Chief Resident. During his time at Stamford Hospital, he developed and implemented a resident education system to help improve resident knowledge, patient care and patient outcomes. He then completed a fellowship in cardiovascular diseases at the University of Tennessee Health Science Center in Memphis, Tennessee, and his advanced heart failure and transplant cardiology fellowship at Mayo Clinic College of Medicine in Jacksonville.

Dr. Goswami has a background in information technology and is focused on innovation and clinical research. He also is an avid mountaineer and climbed Mount Kilimanjaro with his father in 2016.